$Invesco QQQ(QQQ)$ The bear case for $SELLAS Life Sciences Group Inc.(SLS)$ keeps getting more interesting.
First, the arguments were:
- "GPS doesn't work"
- "REGAL will fail before it finishes"
- "They'll run out of cash"
- "Dilution will destroy shareholders"
- "80 events are coming any day now"
Now we've reached the point where the new claim is: "They'll just fraud the data."
It's a pattern where when old narratives fall apart, new ones get created.
Meanwhile, the actual facts remain:
- Phase 3 REGAL trial is still ongoing.
- The IDMC cleared the trial to continue.
- The final event threshold still hasn't been reached.
- The FDA approved unlimited dosing.
- An Expanded Access Program exists.
You can debate the science, the statistics, or the valuation.
But suggesting they'll fake the data isn't analysis; it feels more like desperation.
In the end, what matters is what the REGAL data shows.
Comments